-
2022/10/21Congratulations on the official release of the Blue Book on the Development and Clinical Application of Blood Products in China!This book describes in detail the definition and function, classification and development, preparation process and quality control of blood products.View Details
-
2022/05/05Shanghai RAAS Becomes the Exclusive Distributor of Grifols Nucleic Acid Testing Solution in ChinaOn April 15, 2022, Shanghai RAAS Blood Products Co., Ltd. ("Shanghai RAAS") and Grifols ("Grifols") signed a cooperation agreement to confirm that Shanghai RAAS and its subsidiaries Tonglu Biopharmaceutical Co., Ltd.View Details
-
2022/02/14ShanghaiRAAS was awarded the title of "Leading Enterprise of Oriental Beauty Valley"On February 11th, Dongfang Meigu Enterprise Group Co., Ltd. held the oath ceremony for Dongfang Meigu to depart again and win the "Three Great Battles" in 2022.View Details
-
2022/01/14Shanghai RAAS Won Excellent Business Practice Award in the Pharmaceutical and Biological Industry2021 Financial Leadership in China "Golden Intelligence Award" Listed Company Value Selection Revealed, ShanghaiRAAS Won Excellent Business Practice Award in the Pharmaceutical and Biological IndustryView Details
-
2022/01/04Shanghai RAAS Wins the Gold Award of the 9th Shanghai Fengxian District Mayor's Quality AwardThis book provides a detailed description of the definition and function, classification and development, preparation process, and quality control of blood products.View Details
-
2021/12/30Good news! Zhengzhou RAAS Intravenous Injection of Human Immunoglobulin (pH4) Resumption of ProductionZhengzhou RAAS Blood Products Co., Ltd. , a wholly-owned subsidiary of Shanghai RAAS Blood Products, has been committed to optimizing the product process.View Details
- Home
- Products
- News
- Career
-
Investor Relations
- About RAAS